GLPG Galapagos NV ADRs

Galapagos NV is a clinical-stage biotechnology company. It is engaged in the discovery and development of small molecule medicines which address unmet medical conditions. This is an ADR of a company whose stock trades outside of the U.S. as the symbol NA:GLPG.

$75.04  -1.12 (-1.47%)
As of 05/07/2021 15:59:55 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Belgium
Country of incorporation:  Belgium
IPO date:  07/07/2008
Outstanding shares:  65,511,581
Average volume:  282,533
Market cap:   $5,037,840,579
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    36315X101
ISIN:        US36315X1019
Sedol:      B292NQ7

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   1.87
PS ratio:   8.20
Return on equity:   -11.44%
Net income %:   -59.70%